How to recognize treat and epilepsy in the elderly
- MOJ Gerontology & Geriatrics
Ana Paula Ferreira Silva Sakai,1 Claudia Pinheiro Salles Gomes Rego2
The Increase in life expectancy has led to a progressive growth in chronic degenerative diseases and neurological disorders such as epilepsy, defined the brain by Caused disorder Persistent predisposition of the brain to generate epileptic seizures, with neurobiological, cognitive and psycho-social policies, que Affects Approximately 1% of the world's population. It is of multifactorial origin, and has the cerebrovascular disease of the most common etiology in this specific cohort. Thus, it is Necessary to know the peculiarities of the aging process and to identify the particular presentations of early these seizures in the elderly, and qualified through the broad approach.
Diagnosis in this population can be hampered by atypical presentation and comorbidities. The focal crises are more frequent, with less prominent auras and automatisms and with longer duration of the post-ictal confusion. Status epilepticus is common, with high mortality rate.
Treatment at this age group is challenging because of drug pharmacokinetic and pharmacodynamic changes, polypharmacy, drug interactions, low compliance, and cognitive problems. It must be stipulated carefully considering the safety, tolerability and effectiveness of the medication, are que there are no Consequences que lead to deterioration of the quality of life, loss of functionality and autonomy.
Seizures can be commonly controlled with low doses of a single antiepileptic medication (AEM). Drug-resistant epilepsy is uncommon.
The aim of this review was to understand the clinical manifestations, etiology and the best therapeutic options available for epilepsy in the elderly population.
It is concluded que, despite the existence of a collection of papers related to epilepsy, there is still little scientific data on this subject in this population, especially in extreme frail elderly. Therefore, there is a need for more studies in this area with the greater inclusion of the elderly in clinical trials, as well as the development of models for the comprehensive care of care these patients.
signs and symptoms, diagnosis, epilepsy, therapeutic, anticonvulsivants, aged, chronic degenerative diseases, neurological manifestations, behavioural, psychiatric, cognitivas, spontaneous seizure, patient profile, adverse effects, interactions, comorbidities, epileptic syndrome, neurobiological consequences